Flow Cytometry – Products

Annexin V Starbright™ conjugates offer increased choice and flexibility for apoptosis detection in conventional and full spectrum flow cytometry.

Consistent GMP-grade products are crucial as key raw materials for safe and reliable cell manufacturing. We adhere to stringent regulatory guidelines to provide high-quality GMP biomaterials for various cell culture and differentiation.

Consistent GMP-grade products are crucial as key raw materials for safe and reliable cell and Gene therapy (CGT) manufacturing. We adhere to stringent regulatory guidelines to provide high-quality GMP biomaterials for various CGT applications.

Cytokine detection is an essential assay throughout the drug development process, especially in cell therapies. The measurement of cytokine levels and soluble receptors is commonly used across the therapeutic development cycle to monitor and evaluate immune or cellular response. Through ELISA or flow cytometry, our products are designed to help you quickly cytokine secretion.

This whitepaper explores the advantages of a novel cell sorting and dispensing platform – which combines microfluidics, flow cytometry and liquid dispensing – that can help researchers get to their optimal clones more efficiently.

Bio-Rad’s range of Starbright dyes conjugated to highly validated antibodies now totals 32 dyes, providing greater choice and flexibility for conventional and full-spectrum flow cytometry in immunology research.

Agilent Technologies Inc. has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility.

Instrument Breaks the Boundaries of EV Detection, Providing Access to New Data Points.

Cyto-Mine® can simplify and accelerate your day-to-day operations in cell line development, antibody discovery, and beyond. It’s powered by our picodroplet technology to screen and analyze millions of individual cells and isolate those rare ‘hits’ with monoclonality assured. And all in a single, integrated platform with minimal ‘hands-on’ time.

The project aims to investigate cell types present in coronary artery samples from patients with CAD participating in PlaqueTec’s BIOPATTERN trial. The Assay will be available as a service in the Babraham Institute’s Flow Cytometry Facility.